Integrated Chemotherapeutic Reprogramming and Targeted Senotherapeutic Clearance Elicits Near-Complete (80-89%) Restoration of Youthful Multi-Omic Profiles and Systemic Physiological Resilience". Summary The document presents a novel, non-neurological framework for whole-body rejuvenation. Developed by Nabinjyoti Behera and NAFVNA Pharmaceuticals, the approach uses a biomimetic lead compound to facilitate de novo cellular regeneration and a "somatic reboot" of aged tissue.
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Ethical Compliance & Methodological Disclosure Simulated Nature: This manuscript presents drug discovery, synthesis, and toxicology for educational and conceptual advancement. No Live Trials: No human or animal subjects were involved in this research. Licensing Constraints: No physical synthesis, extraction, or in vivo testing was performed due to license limitations. Data Sources: Outcomes are derived from validated computational models, literature benchmarks, and established algorithms. Non-Clinical Readiness: This framework is not intended for clinical use or immediate medical application.
Fields of Study & Subjects
Telomeres
Telomerase
and Senescence
Genetics
Aging
and Longevity in Model Organisms
Pluripotent Stem Cells Research
Publication details
- Publication date
- 1 January 2026
- Language
- EN
- Document type
- Preprint